Literature DB >> 11927790

Hypertension in the elderly: a review of the importance of systolic blood pressure elevation.

Jan Basile1.   

Abstract

The elderly, those 65 years of age and older, will account for 20% of the population by the year 2040. Hypertension affects more than one half of the elderly and its prevalence continues to increase with age. The presence of hypertension confers an increased risk of stroke, congestive heart failure, coronary heart disease, end-stage renal disease, and death. Although both diastolic and systolic blood pressure elevations are independently associated with increased cardiovascular risk in the younger individual, as vascular compliance becomes reduced at age 60, an increasing systolic blood pressure and lower diastolic blood pressure (or wider pulse pressure) increase cardiovascular risk in the elderly. Isolated systolic hypertension is the most common form of hypertension seen in the elderly. Lifestyle modification, including weight loss and salt restriction, reduces blood pressure, and may decrease the need for pharmacologic therapy. When the systolic blood pressure is 160 mm Hg or more and the diastolic blood pressure is <90 mm Hg, the initial use of a diuretic-based or calcium channel blocker-based regimen improves outcome. Alpha blocker therapy should not be used as initial monotherapy. Most elderly hypertensives will require two to three drugs to achieve the present blood pressure goal of <140 mm Hg. Caution should be exercised when lowering diastolic pressure to <55 mm Hg in those with isolated systolic hypertension. Although side effects of therapy are no more likely to occur in the elderly than in the younger individual with hypertension, blood pressure reduction should be accomplished gradually. (c)2002 Le Jacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927790      PMCID: PMC8101817          DOI: 10.1111/j.1524-6175.2001.00903.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Antihypertensive drug therapies and the risk of ischemic stroke.

Authors:  O H Klungel; S R Heckbert; W T Longstreth; C D Furberg; R C Kaplan; N L Smith; R N Lemaitre; H G Leufkens; A de Boer; B M Psaty
Journal:  Arch Intern Med       Date:  2001-01-08

2.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

3.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

4.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors:  M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

5.  Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Authors:  L Hansson; T Hedner; P Lund-Johansen; S E Kjeldsen; L H Lindholm; J O Syvertsen; J Lanke; U de Faire; B Dahlöf; B E Karlberg
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.

Authors:  P K Whelton; L J Appel; M A Espeland; W B Applegate; W H Ettinger; J B Kostis; S Kumanyika; C R Lacy; K C Johnson; S Folmar; J A Cutler
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

8.  Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

Authors:  L V Franse; M Pahor; M Di Bari; G W Somes; W C Cushman; W B Applegate
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

9.  Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials.

Authors:  J A Staessen; J Gasowski; J G Wang; L Thijs; E Den Hond; J P Boissel; J Coope; T Ekbom; F Gueyffier; L Liu; K Kerlikowske; S Pocock; R H Fagard
Journal:  Lancet       Date:  2000-03-11       Impact factor: 79.321

10.  Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; D Levy
Journal:  Hypertension       Date:  1999-09       Impact factor: 10.190

View more
  7 in total

1.  A high-salt diet further impairs age-associated declines in cognitive, behavioral, and cardiovascular functions in male Fischer brown Norway rats.

Authors:  Gaurav Chugh; Mohammad Asghar; Gaurav Patki; Ritu Bohat; Faizan Jafri; Farida Allam; An T Dao; Christopher Mowrey; Karim Alkadhi; Samina Salim
Journal:  J Nutr       Date:  2013-07-17       Impact factor: 4.798

2.  Ten years and counting: the journal of clinical hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 3.738

3.  Association between sleep quality and arterial blood pressure among Chinese nonagenarians/centenarians.

Authors:  Yue Ji-Rong; Wang Hui; Huang Chang-Quan; Dong Bi-Rong
Journal:  Med Sci Monit       Date:  2012-03

Review 4.  A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours.

Authors:  Philippe Gosse
Journal:  Vasc Health Risk Manag       Date:  2006

5.  Treatment of hypertension in the elderly.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738

6.  Trends in educational inequalities in old age mortality in Norway 1961-2009: a prospective register based population study.

Authors:  Joakim Oliu Moe; Ólöf Anna Steingrímsdóttir; Bjørn Heine Strand; Else-Karin Grøholt; Øyvind Næss
Journal:  BMC Public Health       Date:  2012-10-27       Impact factor: 3.295

7.  Cardiorespiratory fitness mediates the effects of aging on cerebral blood flow.

Authors:  Benjamin Zimmerman; Bradley P Sutton; Kathy A Low; Mark A Fletcher; Chin Hong Tan; Nils Schneider-Garces; Yanfen Li; Cheng Ouyang; Edward L Maclin; Gabriele Gratton; Monica Fabiani
Journal:  Front Aging Neurosci       Date:  2014-04-07       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.